STARNSEStrides Pharma Science Limited· PharmaceuticalsMediumNeutral
Announced Wed, 27 May · 13:05 IST

Pronomz Ventures LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

STAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.0%1-day move
₹1165.00
prior close
₹1156.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1-0.1-0.1-3.0-6.2-7.5-7.4-11.9-14.0-5.0-5.2-10.4
Up moveDown movePending
AI summary

Pronomz Ventures LLP, acting on behalf of the Promoters and Promoter Group of Strides Pharma Science Limited, has filed a negative confirmation with NSE and BSE. The disclosure states that the promoters have not created any new share encumbrances (pledges) during the financial year ended March 31, 2026, beyond what was already disclosed previously. This is a routine regulatory filing under SEBI's takeover regulations that requires promoters to confirm their pledge status periodically.

Likely market impact

This is a neutral filing for shareholders as it confirms no additional promoter share pledges were created during the year. The absence of new encumbrances is a positive sign indicating promoters have not leveraged their holdings further, reducing potential dilution risk for minority shareholders.